Tejara Capital’s TherapeuticsMD TXMD Stock Holding History

Tejara Capital’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$761K	Sell	344,482 -1,370	-0.4%	-$2.83K	0.31%	55
2026 Q1	$699K	Sell	345,852 -5,000	-1%	-$11.2K	0.23%	67
2025 Q4	$572K	Buy	350,852 +6,649	+2%	+$9.61K	0.13%	57
2025 Q3	$370K	Sell	344,203 -51	-0%	-$57	0.19%	44
2025 Q2	$399K	Sell	344,254 -341	-0.1%	-$413	0.19%	68
2025 Q1	$319K	Sell	344,595 -50,066	-13%	-$49.9K	0.12%	73
2024 Q4	$339K	Sell	394,661 -6,785	-2%	-$9.55K	0.22%	50
2024 Q3	$666K	Sell	401,446 -491	-0.1%	-$855	0.32%	48
2024 Q2	$647K	Hold	401,937	–	–	0.24%	55
2024 Q1	$920K	Hold	401,937	–	–	0.34%	52
2023 Q4	$904K	Buy	401,937 +32,343	+9%	+$78K	0.38%	48
2023 Q3	$1.12M	Hold	369,594	–	–	0.63%	38
2023 Q2	$1.52M	Buy	369,594 +13,915	+4%	+$54.6K	0.75%	35
2023 Q1	$1.33M	Buy	355,679 +38,366	+12%	+$184K	0.68%	39
2022 Q4	$1.77M	Buy	+317,313	New	+$1.87M	1.02%	28

Other funds holding TXMD

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Clearline Capital New York $1.68B AUM 53.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Tejara Capital's TXMD Position: Q2 2026 in Review

Tejara Capital reduced its TherapeuticsMD (TXMD) stake by 0.4% in Q2 2026, selling an estimated $2.83K and leaving 344,482 shares worth $761K. The position accounts for 0.31% of the portfolio, ranked #55.

Tejara Capital first reported a position in TXMD in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.77M in Q4 2022. 44 funds tracked by Wall St. Rank hold TXMD as of Q2 2026.

Tejara Capital held 344,482 shares of TherapeuticsMD worth $761K as of Q2 2026.
Tejara Capital sold 1,370 TherapeuticsMD shares in Q2 2026, an estimated $2.83K.
TherapeuticsMD made up 0.31% of Tejara Capital's portfolio in Q2 2026, its #55 holding.
Tejara Capital first reported a position in TherapeuticsMD in Q4 2022 and has held it in 15 quarters since.
Tejara Capital's TherapeuticsMD position peaked at $1.77M in Q4 2022.
44 funds tracked by Wall St. Rank held TherapeuticsMD as of Q2 2026.

Based on Tejara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.